Navigation Links
European Hearing Aids and Audiology Devices Market
Date:3/7/2013

NEW YORK, March 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Hearing Aids and Audiology Devices Market

http://www.reportlinker.com/p01117758/European-Hearing-Aids-and-Audiology-Devices-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

The European hearing aids and audiology devices market shows that in 2012, 14.5% of the European population suffered from hearing impairment, which amounted to 59.6 million candidates who would benefit from using a hearing device.

Despite the high market potential for hearing aid devices, there is still a great deal of growth remaining in the European hearing aids and audiology devices market, as the penetration of hearing aid users in Europe is less than 20%. Growth of the hearing device market is largely dependent on the reimbursement policies of each country, the technological innovations that are offered by the manufacturers and the distribution of hearing aids by the retailers to the end users. The adoption rate of hearing aid users is expected to increase at a CAGR of 2%, leading to over 20% penetration by 2019.

Scope:

The European Hearing Aids and Audiology Devices Market report pertains to a forecast period of 10 years (2009 – 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, '/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
2. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
3. BioElectronics Expands European Distribution to Malta
4. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
5. Cardica Updates Enrollment Progress In European Clinical Trial
6. Hologic to Showcase Game-Changing Breast Tomosynthesis Technology and Other Product Innovations at the European Congress of Radiology in Vienna
7. Gro-International to Develop BioElectronics OTC Brands in European and African Markets
8. European Diagnostic Imaging System Market Will Grow Modestly To Almost $2.2 Billion In 2017
9. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
10. Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Companys Patented "IPF" HIV-AIDS Medicines
11. OrbusNeich Announces Favorable Ruling From the European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... and sale of patented biopharmaceutical medicine, modernized traditional Chinese ... today announced the business and development progress at its ... Following the September 2014 JCM application (No. 51268) for ...
(Date:1/22/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a ... cardiovascular disease and overall health is pleased to provide you ... its outlook for 2015 from the CEO, Mr. Eugene ... would like to take this opportunity to share with you ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... today announced positive results from a Phase 1 trial ... in vitro anti-pseudomonal activity. The results from ... well tolerated, with a clinical and laboratory safety profile ... toxicity was observed, even at the highest dose regimen ...
... 23 Each year in the United States more than ... These new cases account for 10 percent of the new ... several types of leukemia, the survival rate has not changed ... Golubieski, president of Foundation Venture Capital Group, LLC, a New ...
Cached Medicine Technology:Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity 2Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, ... Health Alliance (PPHA). The PPHA's passion for others' well-being ... NFL greats, treated for obstructive sleep apnea (OSA) has propelled ... cause in the valley. The most recent plans for an ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... eye disease, research suggests, , FRIDAY, Jan. 14 (HealthDay News) ... too much sodium increase their risk for eye disease, a ... who had type 1 diabetes. Six years later, they underwent ... taken of their eyes to determine the progression of diabetic ...
... NEW YORK , Jan. 15 , ... the thousands of other victims from the earthquake tragedy that struck ... Haiti completely devastated the country with untold numbers of ... Haitians and every nation,s citizens devastated by the quake, please join ...
... major malignant diseases worldwide. Surgery alone cannot obtain ... has been a hotspot for EC treatment research. ... published, but opinions vary among clinicians as to ... remains uncertain whether patients with resectable EC can ...
... ... to Summit Medical Group,s Sleep Center. , ... Berkeley Height, N.J. (Vocus) January 15, 2010 -- The Sleep ... American Academy of Sleep Medicine. The Sleep Disorders Center at Summit Medical Group provides ...
... department, federal report shows , THURSDAY, Jan. 14 (HealthDay ... motor vehicle crash victims who had injuries ranging from ... new government study finds. , About 85 percent (3 ... were admitted or transferred to another acute care hospital ...
... Jan. 15 Equinox Holdings, Inc. (the "Company") ... to eligible purchasers, subject to market and other conditions, of ... due 2016 (the "Notes").  The Notes will be guaranteed on ... and future subsidiaries that guarantee the Company,s new revolving credit ...
Cached Medicine News:Health News:Blacks With Diabetes Urged to Cut Calories, Salt 2Health News:Summit Medical Group's Sleep Disorders Center Granted Accreditation 2Health News:Equinox Holdings, Inc. Commences $400 Million Private Debt Offering 2
... Thermal Cycler is one of the smallest ... Benefits include: Fast ramping, low cost, ... and program naming, Ready-to-go templates, interchangeable blocks. ... Biology and Diagnostic laboratories and is suitable ...
... the smallest footprint two-bay thermal cycler available, ... The Disciple instrument is operated ... a computer using a remote command set. ... contains the latest in power electronics technology ...
PTC-100 thermal cycler, holds sixteen 25x75mm microscope slides & 24x0.2ml tubes...
Px2 thermal Cycler chassis (requires block). Multiple interchangeable blocks. Gradient capability. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced r...
Medicine Products: